Channels - The natural history of Efavirenz Drug Induced liver injury :: FRELIP Discovery

Similar Items: The natural history of Efavirenz Drug Induced liver injury

Quick Look
Proteomic insights into the modulation of foetal neurogenesis by the anti-retroviral efavirenz
Quick Look
Edible Fungus Compound Cordycepin Protects Against Acetaminophen‐Induced Liver Injury
Quick Look
Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients
Quick Look
Not your usual drug-induced liver injury: Dolutegravir-associated granulomatous hepatitis
Quick Look
Severe Neurotoxicity Associated with supra-therapeutic Efavirenz concentrations: a retrospective cohort study
Quick Look
Mechanisms of drug-induced cardiotoxicity and translational potential of natural products in cardio protection
Quick Look
N-Acetylcysteine for non-paracetamol drug-induced liver injury: A systemic review
Quick Look
Determination of total, unbound, and intracellular concentrations of the antiretroviral drugs Efavirenz, Lopinavir, and Ritonavir
Quick Look
Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa
Quick Look
Newly Identified Mechanisms of Total Parenteral Nutrition Related Liver Injury
Quick Look
A randomised controlled trial of N-acetylcysteine in the management of anti-tuberculosis drug-induced liver injury
Quick Look
Integrating multi-type features and knowledge graph for graded prediction of drug-induced liver injury in humans
Quick Look
Development and Validation of Bioanalytical Method for Efavirenz in Dried Blood Spot Using High Performance Liquid Chromatography–Photodiode Array
Quick Look
Rates of Switching First-Line Antiretroviral Regimen Tenofovir-Emtricitabine-Efavirenz combination in a Primary Care Service in South Africa
Quick Look
A systematic review of agomelatine-induced liver injury
Quick Look
Kava Herb-Induced Liver Injury as Verified by the Updated RUCAM
Quick Look
The Fumonisin B1-Fed Rat as a model for liver injury, oval Progenitor') cell proliferation, and carcinogenesis
Quick Look
Costs, Demographics, and Causative Agents in Patients Hospitalized for Drug Induced Liver Injury: Trends in a Large Academic Healthcare System
Quick Look
The role of "non-alcoholic steatohepatitis (NASH)" in methotrexate induced liver injury
Quick Look
IRF‐1 modulates hepatic ferroptosis and aggravates liver ischemia/reperfusion injury via DYRK1α
Quick Look
Neuropsychiatric complications of efavirenz in children with HIV-1 infection
Quick Look
Efavirenz pharmacogenetics and metabolic toxicity in black South Africans
Quick Look
Approaches for Predicting Storage-Induced Reactive Impurities in Pharmaceutical Drugs
Quick Look
Amoxicillin-Induced Drug-Induced Liver Injury Superimposed on Acute Hepatitis C Infection in a Patient With Hurler Syndrome: A Diagnostic Challenge Assessed by the Updated RUCAM

Author: Spearman, Catherine Wendy

Quick Look
The natural history of Efavirenz Drug Induced liver injury

Author: Maughan, Deborah

Quick Look
The natural history of Efavirenz Drug Induced liver injury